Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Membrane Transport Proteins | 40 | 2005 | 1031 | 4.310 |
Why?
|
Cocaine | 56 | 2020 | 958 | 3.720 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 56 | 2014 | 415 | 3.140 |
Why?
|
Membrane Glycoproteins | 40 | 2005 | 3696 | 2.690 |
Why?
|
Nerve Tissue Proteins | 40 | 2005 | 4404 | 2.630 |
Why?
|
Dopamine | 30 | 2014 | 1601 | 2.150 |
Why?
|
Dopamine Uptake Inhibitors | 16 | 2020 | 297 | 2.080 |
Why?
|
Carrier Proteins | 38 | 2003 | 4935 | 1.940 |
Why?
|
Corpus Striatum | 19 | 2020 | 1234 | 1.280 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 21 | 2012 | 325 | 1.250 |
Why?
|
Hallucinogens | 2 | 2022 | 197 | 1.210 |
Why?
|
Cannabidiol | 2 | 2021 | 118 | 1.180 |
Why?
|
Opioid-Related Disorders | 6 | 2024 | 2164 | 1.150 |
Why?
|
Receptors, Dopamine D1 | 13 | 2020 | 292 | 1.120 |
Why?
|
Brain Chemistry | 16 | 2005 | 959 | 1.100 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 8 | 2008 | 66 | 1.090 |
Why?
|
Receptors, Dopamine D2 | 12 | 2020 | 485 | 1.010 |
Why?
|
Macaca fascicularis | 32 | 2008 | 901 | 0.980 |
Why?
|
Receptors, Dopamine | 20 | 2020 | 295 | 0.930 |
Why?
|
Marijuana Abuse | 2 | 2019 | 410 | 0.850 |
Why?
|
Putamen | 18 | 2006 | 292 | 0.840 |
Why?
|
Receptors, Drug | 11 | 2001 | 157 | 0.840 |
Why?
|
Tropanes | 6 | 2003 | 48 | 0.840 |
Why?
|
Macaca mulatta | 24 | 2020 | 2328 | 0.840 |
Why?
|
Membrane Transport Modulators | 5 | 2005 | 24 | 0.800 |
Why?
|
Saimiri | 21 | 2021 | 333 | 0.800 |
Why?
|
Caudate Nucleus | 17 | 2020 | 390 | 0.790 |
Why?
|
Cannabis | 2 | 2018 | 441 | 0.760 |
Why?
|
Vesicular Monoamine Transport Proteins | 2 | 2015 | 32 | 0.740 |
Why?
|
Methylphenidate | 7 | 2008 | 488 | 0.730 |
Why?
|
Brain | 41 | 2024 | 27092 | 0.710 |
Why?
|
Tomography, Emission-Computed | 16 | 2005 | 1123 | 0.660 |
Why?
|
Substance-Related Disorders | 8 | 2024 | 4413 | 0.650 |
Why?
|
Radioligand Assay | 14 | 2010 | 366 | 0.640 |
Why?
|
Organotechnetium Compounds | 4 | 2003 | 132 | 0.630 |
Why?
|
Neurobiology | 2 | 2013 | 137 | 0.620 |
Why?
|
Cocaine-Related Disorders | 4 | 2020 | 460 | 0.610 |
Why?
|
Behavior, Animal | 10 | 2021 | 1873 | 0.610 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 3 | 2008 | 65 | 0.590 |
Why?
|
Marijuana Smoking | 2 | 2018 | 258 | 0.590 |
Why?
|
Citalopram | 9 | 2008 | 402 | 0.590 |
Why?
|
Drug and Narcotic Control | 3 | 2018 | 144 | 0.580 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 12 | 2013 | 1130 | 0.580 |
Why?
|
Dopamine Agonists | 6 | 2006 | 352 | 0.570 |
Why?
|
Designer Drugs | 1 | 2017 | 21 | 0.560 |
Why?
|
Binding, Competitive | 18 | 2006 | 1140 | 0.550 |
Why?
|
Alcohol Drinking | 2 | 2019 | 4027 | 0.520 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 12 | 2012 | 3707 | 0.520 |
Why?
|
Narcotics | 1 | 2018 | 336 | 0.510 |
Why?
|
Dopamine Agents | 7 | 2001 | 189 | 0.510 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2007 | 1249 | 0.490 |
Why?
|
Stereoisomerism | 15 | 2006 | 611 | 0.470 |
Why?
|
Tritium | 15 | 2005 | 706 | 0.470 |
Why?
|
Serotonin | 11 | 2005 | 1042 | 0.470 |
Why?
|
Symporters | 3 | 2005 | 363 | 0.460 |
Why?
|
Narcotic Antagonists | 1 | 2018 | 585 | 0.450 |
Why?
|
Central Nervous System Stimulants | 8 | 2017 | 1176 | 0.420 |
Why?
|
Cannabinoids | 4 | 2017 | 172 | 0.420 |
Why?
|
Psychotropic Drugs | 2 | 2017 | 885 | 0.410 |
Why?
|
Structure-Activity Relationship | 15 | 2012 | 3057 | 0.400 |
Why?
|
Proto-Oncogene Proteins c-fos | 4 | 2007 | 582 | 0.390 |
Why?
|
Analgesics, Opioid | 5 | 2024 | 3805 | 0.390 |
Why?
|
Haloperidol | 2 | 2013 | 390 | 0.390 |
Why?
|
Iodine Radioisotopes | 8 | 2001 | 1030 | 0.380 |
Why?
|
Octanes | 2 | 2003 | 3 | 0.380 |
Why?
|
Politics | 1 | 2018 | 814 | 0.370 |
Why?
|
Parkinsonian Disorders | 2 | 2006 | 285 | 0.350 |
Why?
|
Pyrrolidines | 2 | 2017 | 339 | 0.350 |
Why?
|
Animals | 102 | 2024 | 168079 | 0.340 |
Why?
|
Benzhydryl Compounds | 3 | 2010 | 917 | 0.330 |
Why?
|
Drug Discovery | 2 | 2018 | 1050 | 0.330 |
Why?
|
Ligands | 13 | 2006 | 3264 | 0.320 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 5 | 2001 | 89 | 0.310 |
Why?
|
Appetitive Behavior | 1 | 2008 | 39 | 0.300 |
Why?
|
Desipramine | 1 | 2008 | 182 | 0.290 |
Why?
|
Discrimination Learning | 2 | 2008 | 278 | 0.290 |
Why?
|
Piperidines | 4 | 2001 | 1656 | 0.280 |
Why?
|
Autoradiography | 10 | 2006 | 729 | 0.280 |
Why?
|
Norepinephrine | 4 | 2006 | 897 | 0.270 |
Why?
|
Parkinson Disease | 7 | 1998 | 2867 | 0.270 |
Why?
|
Pentanones | 1 | 2006 | 12 | 0.270 |
Why?
|
Association Learning | 1 | 2008 | 221 | 0.260 |
Why?
|
Receptor, EphA4 | 1 | 2005 | 17 | 0.260 |
Why?
|
Receptor, EphB2 | 1 | 2005 | 26 | 0.260 |
Why?
|
Dose-Response Relationship, Drug | 12 | 2021 | 10756 | 0.260 |
Why?
|
Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2005 | 23 | 0.260 |
Why?
|
Serotonin Agents | 1 | 2005 | 29 | 0.260 |
Why?
|
Positron-Emission Tomography | 7 | 2014 | 6585 | 0.250 |
Why?
|
Parents | 1 | 2019 | 3564 | 0.250 |
Why?
|
Alkenes | 1 | 2004 | 54 | 0.240 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2006 | 186 | 0.240 |
Why?
|
Neostriatum | 4 | 2001 | 247 | 0.240 |
Why?
|
Adaptation, Physiological | 3 | 2006 | 1301 | 0.230 |
Why?
|
3' Untranslated Regions | 3 | 2012 | 514 | 0.230 |
Why?
|
Catechols | 1 | 2003 | 62 | 0.220 |
Why?
|
Piperazines | 5 | 2001 | 2522 | 0.220 |
Why?
|
Cognition | 1 | 2021 | 6988 | 0.220 |
Why?
|
Phenylacetates | 1 | 2003 | 111 | 0.210 |
Why?
|
Pyrans | 1 | 2003 | 49 | 0.210 |
Why?
|
Drug Tolerance | 2 | 2021 | 367 | 0.210 |
Why?
|
Receptors, Opioid, mu | 1 | 2004 | 167 | 0.210 |
Why?
|
Amphetamine | 3 | 2007 | 224 | 0.200 |
Why?
|
Emotions | 1 | 2014 | 2742 | 0.200 |
Why?
|
Antipsychotic Agents | 5 | 2013 | 3064 | 0.200 |
Why?
|
Cell Line | 9 | 2008 | 15545 | 0.190 |
Why?
|
Psychoses, Substance-Induced | 2 | 2017 | 99 | 0.190 |
Why?
|
Motor Activity | 7 | 2003 | 2712 | 0.190 |
Why?
|
Neurotoxicity Syndromes | 1 | 2005 | 301 | 0.190 |
Why?
|
Binding Sites | 15 | 2003 | 5988 | 0.190 |
Why?
|
Parkinson Disease, Secondary | 3 | 1997 | 122 | 0.190 |
Why?
|
Mazindol | 3 | 2001 | 13 | 0.180 |
Why?
|
Nitrogen | 2 | 2001 | 345 | 0.170 |
Why?
|
Male | 67 | 2020 | 360693 | 0.160 |
Why?
|
Gene Expression Regulation | 4 | 2006 | 11856 | 0.160 |
Why?
|
Nortropanes | 2 | 1997 | 12 | 0.160 |
Why?
|
Phenanthridines | 4 | 2006 | 51 | 0.160 |
Why?
|
Impulsive Behavior | 1 | 2002 | 346 | 0.160 |
Why?
|
Inpatients | 1 | 2011 | 2545 | 0.160 |
Why?
|
Humans | 62 | 2024 | 761208 | 0.160 |
Why?
|
Tissue Distribution | 7 | 2000 | 2263 | 0.160 |
Why?
|
Aggression | 1 | 2004 | 748 | 0.160 |
Why?
|
Neurotransmitter Uptake Inhibitors | 3 | 1994 | 36 | 0.160 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1651 | 0.160 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3691 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2004 | 15920 | 0.150 |
Why?
|
Tryptophan | 9 | 1975 | 480 | 0.150 |
Why?
|
Substance Abuse Detection | 3 | 2017 | 301 | 0.150 |
Why?
|
Alcoholism | 1 | 2008 | 1973 | 0.150 |
Why?
|
Propiophenones | 2 | 2017 | 28 | 0.150 |
Why?
|
Heroin | 1 | 2018 | 119 | 0.140 |
Why?
|
Health Policy | 1 | 2010 | 2679 | 0.140 |
Why?
|
Nucleus Accumbens | 1 | 2020 | 365 | 0.140 |
Why?
|
Nerve Endings | 2 | 1996 | 105 | 0.140 |
Why?
|
Receptors, Serotonin | 3 | 1994 | 208 | 0.140 |
Why?
|
Transfection | 5 | 2007 | 5748 | 0.140 |
Why?
|
Cloning, Molecular | 4 | 2005 | 4167 | 0.140 |
Why?
|
Task Performance and Analysis | 1 | 2021 | 763 | 0.140 |
Why?
|
Mental Disorders | 1 | 2017 | 6823 | 0.140 |
Why?
|
Melatonin | 1 | 2002 | 668 | 0.130 |
Why?
|
Aminopyridines | 1 | 2000 | 573 | 0.130 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15841 | 0.130 |
Why?
|
Benztropine | 1 | 1996 | 17 | 0.130 |
Why?
|
Carbon Radioisotopes | 6 | 2010 | 561 | 0.130 |
Why?
|
Stress, Physiological | 1 | 2004 | 1405 | 0.130 |
Why?
|
Administration, Oral | 4 | 2017 | 4015 | 0.130 |
Why?
|
Stereotyped Behavior | 2 | 2008 | 135 | 0.130 |
Why?
|
Naphthalenes | 1 | 2017 | 198 | 0.130 |
Why?
|
Molecular Sequence Data | 6 | 2006 | 17598 | 0.130 |
Why?
|
Phenethylamines | 2 | 2006 | 95 | 0.130 |
Why?
|
Alkaloids | 1 | 2017 | 191 | 0.130 |
Why?
|
Female | 44 | 2020 | 392544 | 0.120 |
Why?
|
Benzazepines | 4 | 2006 | 310 | 0.120 |
Why?
|
Mass Screening | 1 | 2011 | 5426 | 0.120 |
Why?
|
Parent-Child Relations | 1 | 2019 | 762 | 0.120 |
Why?
|
Molecular Structure | 4 | 2012 | 1875 | 0.120 |
Why?
|
Fentanyl | 1 | 2018 | 433 | 0.120 |
Why?
|
Methamphetamine | 1 | 2017 | 165 | 0.120 |
Why?
|
Marketing | 1 | 2017 | 220 | 0.120 |
Why?
|
Amino Acid Sequence | 5 | 2006 | 13402 | 0.120 |
Why?
|
Models, Animal | 1 | 2021 | 2115 | 0.120 |
Why?
|
Hallucinations | 1 | 2017 | 366 | 0.110 |
Why?
|
Schizophrenia | 1 | 2013 | 6930 | 0.110 |
Why?
|
Indoles | 2 | 2017 | 1830 | 0.110 |
Why?
|
Substantia Nigra | 3 | 2007 | 347 | 0.110 |
Why?
|
Radiopharmaceuticals | 1 | 2003 | 2683 | 0.110 |
Why?
|
Kinetics | 6 | 2005 | 6312 | 0.110 |
Why?
|
Gene Expression | 1 | 2006 | 7571 | 0.110 |
Why?
|
Dibenzazepines | 2 | 1983 | 26 | 0.110 |
Why?
|
Behavior, Addictive | 2 | 2017 | 462 | 0.110 |
Why?
|
Mianserin | 2 | 1983 | 51 | 0.110 |
Why?
|
Fluoxetine | 1 | 1996 | 728 | 0.100 |
Why?
|
Alleles | 4 | 2013 | 6857 | 0.100 |
Why?
|
Quinolines | 3 | 2006 | 764 | 0.100 |
Why?
|
Psychomotor Performance | 1 | 2021 | 1880 | 0.100 |
Why?
|
Drug Utilization | 1 | 2018 | 1188 | 0.100 |
Why?
|
Interviews as Topic | 1 | 2019 | 2697 | 0.100 |
Why?
|
Hypnotics and Sedatives | 1 | 2000 | 1178 | 0.100 |
Why?
|
Ephrin-B3 | 1 | 2011 | 12 | 0.100 |
Why?
|
Rats | 16 | 2020 | 23704 | 0.100 |
Why?
|
Carboxylic Acids | 1 | 2012 | 90 | 0.100 |
Why?
|
GAP-43 Protein | 1 | 2011 | 152 | 0.100 |
Why?
|
Depression | 2 | 2022 | 8132 | 0.100 |
Why?
|
Cyclic AMP | 2 | 2006 | 1462 | 0.090 |
Why?
|
Indans | 1 | 1992 | 92 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2006 | 3770 | 0.090 |
Why?
|
Esters | 1 | 2012 | 210 | 0.090 |
Why?
|
Raclopride | 1 | 2010 | 101 | 0.090 |
Why?
|
Ascorbic Acid | 3 | 1983 | 654 | 0.090 |
Why?
|
Circadian Rhythm | 1 | 2002 | 2569 | 0.090 |
Why?
|
Violence | 1 | 2017 | 935 | 0.090 |
Why?
|
Protein Binding | 9 | 2010 | 9297 | 0.090 |
Why?
|
Blotting, Western | 3 | 2007 | 5032 | 0.090 |
Why?
|
District of Columbia | 1 | 2010 | 159 | 0.080 |
Why?
|
Prefrontal Cortex | 1 | 2000 | 2219 | 0.080 |
Why?
|
Psychotherapy, Brief | 1 | 2011 | 118 | 0.080 |
Why?
|
Hippocampus | 2 | 2011 | 3754 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2001 | 2893 | 0.080 |
Why?
|
Government Agencies | 1 | 2010 | 160 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2020 | 2640 | 0.080 |
Why?
|
Receptors, Dopamine D4 | 2 | 2000 | 169 | 0.080 |
Why?
|
Species Specificity | 3 | 2020 | 2406 | 0.080 |
Why?
|
United States | 4 | 2018 | 72339 | 0.070 |
Why?
|
Reversal Learning | 1 | 2008 | 57 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2220 | 0.070 |
Why?
|
Managed Care Programs | 1 | 2013 | 937 | 0.070 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 3 | 2020 | 54 | 0.070 |
Why?
|
Edetic Acid | 3 | 1983 | 275 | 0.070 |
Why?
|
Autoreceptors | 1 | 2007 | 5 | 0.070 |
Why?
|
Crime | 1 | 2008 | 204 | 0.070 |
Why?
|
Macaca | 1 | 1988 | 410 | 0.070 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2011 | 541 | 0.070 |
Why?
|
Primates | 2 | 2001 | 521 | 0.070 |
Why?
|
Drug Synergism | 2 | 2002 | 1756 | 0.070 |
Why?
|
Dogs | 9 | 1985 | 3832 | 0.070 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 555 | 0.070 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2008 | 392 | 0.070 |
Why?
|
Ephrins | 1 | 2006 | 28 | 0.070 |
Why?
|
Crystallography, X-Ray | 2 | 2001 | 1978 | 0.070 |
Why?
|
Sleep | 1 | 2002 | 4759 | 0.070 |
Why?
|
Models, Chemical | 2 | 1999 | 609 | 0.070 |
Why?
|
Adolescent | 8 | 2019 | 88298 | 0.060 |
Why?
|
Indicators and Reagents | 2 | 2006 | 453 | 0.060 |
Why?
|
Receptors, Dopamine D3 | 1 | 2006 | 108 | 0.060 |
Why?
|
Neuropilin-1 | 1 | 2006 | 90 | 0.060 |
Why?
|
Semaphorins | 1 | 2006 | 96 | 0.060 |
Why?
|
Prescription Drugs | 1 | 2013 | 631 | 0.060 |
Why?
|
Molecular Conformation | 2 | 2006 | 543 | 0.060 |
Why?
|
Acclimatization | 1 | 2005 | 113 | 0.060 |
Why?
|
Vesicular Biogenic Amine Transport Proteins | 1 | 2005 | 9 | 0.060 |
Why?
|
Molecular Probes | 2 | 2000 | 309 | 0.060 |
Why?
|
Anxiety | 1 | 2020 | 4569 | 0.060 |
Why?
|
Community Health Centers | 1 | 2008 | 461 | 0.060 |
Why?
|
Maleimides | 1 | 2005 | 112 | 0.060 |
Why?
|
History, 20th Century | 1 | 2013 | 2765 | 0.060 |
Why?
|
Internet | 1 | 2017 | 3096 | 0.060 |
Why?
|
Spiperone | 5 | 1985 | 31 | 0.060 |
Why?
|
Luciferases | 2 | 2007 | 710 | 0.060 |
Why?
|
Health Personnel | 1 | 2018 | 3337 | 0.060 |
Why?
|
Phenytoin | 2 | 1983 | 190 | 0.060 |
Why?
|
Phosphorylation | 2 | 2005 | 8300 | 0.060 |
Why?
|
Biogenic Amines | 1 | 2003 | 53 | 0.060 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2005 | 818 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1567 | 0.060 |
Why?
|
Response Elements | 1 | 2005 | 306 | 0.050 |
Why?
|
Contrast Media | 1 | 1997 | 5311 | 0.050 |
Why?
|
RNA, Messenger | 4 | 2011 | 12747 | 0.050 |
Why?
|
Public Health | 1 | 2017 | 2672 | 0.050 |
Why?
|
Molecular Weight | 1 | 2005 | 2171 | 0.050 |
Why?
|
Sulfhydryl Reagents | 1 | 2002 | 29 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2005 | 1429 | 0.050 |
Why?
|
Trauma Centers | 1 | 2008 | 938 | 0.050 |
Why?
|
Manganese | 2 | 1983 | 391 | 0.050 |
Why?
|
Macaca nemestrina | 1 | 2002 | 21 | 0.050 |
Why?
|
Minisatellite Repeats | 2 | 2013 | 163 | 0.050 |
Why?
|
Glycosylation | 1 | 2005 | 1095 | 0.050 |
Why?
|
Neurons | 2 | 2020 | 9428 | 0.050 |
Why?
|
Base Sequence | 2 | 2005 | 12404 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4567 | 0.050 |
Why?
|
Genes, Reporter | 2 | 2007 | 1518 | 0.050 |
Why?
|
Membranes | 4 | 1983 | 164 | 0.050 |
Why?
|
Employment | 1 | 2008 | 1114 | 0.050 |
Why?
|
Models, Molecular | 2 | 2005 | 5406 | 0.050 |
Why?
|
Reinforcement Schedule | 2 | 1992 | 123 | 0.050 |
Why?
|
Signal Transduction | 2 | 2020 | 23416 | 0.050 |
Why?
|
Mental Recall | 1 | 2008 | 1221 | 0.050 |
Why?
|
Receptors, Cannabinoid | 1 | 2001 | 43 | 0.050 |
Why?
|
Mutagenesis | 1 | 2005 | 1226 | 0.050 |
Why?
|
Sequence Alignment | 1 | 2006 | 2175 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2006 | 1695 | 0.050 |
Why?
|
Young Adult | 4 | 2019 | 59221 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15721 | 0.050 |
Why?
|
Organ Specificity | 1 | 2005 | 1963 | 0.050 |
Why?
|
Dopamine Antagonists | 5 | 1992 | 288 | 0.050 |
Why?
|
Synapses | 2 | 2002 | 1755 | 0.050 |
Why?
|
Oligonucleotide Probes | 1 | 2001 | 416 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7400 | 0.040 |
Why?
|
Cerebellum | 2 | 2006 | 1501 | 0.040 |
Why?
|
Urban Population | 1 | 2008 | 2036 | 0.040 |
Why?
|
Consensus Sequence | 1 | 2001 | 362 | 0.040 |
Why?
|
Protein Kinase C | 1 | 2005 | 1202 | 0.040 |
Why?
|
Sensory Receptor Cells | 1 | 2005 | 508 | 0.040 |
Why?
|
Carbon Isotopes | 5 | 2006 | 458 | 0.040 |
Why?
|
Mutation | 1 | 2005 | 30002 | 0.040 |
Why?
|
Amines | 1 | 2001 | 280 | 0.040 |
Why?
|
Adult | 13 | 2019 | 221119 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2003 | 1848 | 0.040 |
Why?
|
Chromatography, Gel | 2 | 1995 | 641 | 0.040 |
Why?
|
Oxazines | 2 | 2000 | 349 | 0.040 |
Why?
|
Motor Skills | 2 | 2000 | 521 | 0.040 |
Why?
|
Wakefulness | 1 | 2006 | 1264 | 0.040 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2000 | 165 | 0.040 |
Why?
|
Receptor, trkB | 1 | 2020 | 124 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2020 | 8164 | 0.040 |
Why?
|
Temperature | 1 | 2005 | 2219 | 0.040 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2001 | 781 | 0.040 |
Why?
|
Fatty Acids, Nonesterified | 4 | 1975 | 392 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.040 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2001 | 489 | 0.040 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 1998 | 91 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1681 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26071 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 1 | 1999 | 464 | 0.040 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2020 | 412 | 0.040 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2001 | 370 | 0.040 |
Why?
|
Rural Population | 1 | 2008 | 2277 | 0.040 |
Why?
|
HIV Infections | 1 | 2024 | 17347 | 0.040 |
Why?
|
Receptors, Cell Surface | 2 | 2006 | 2802 | 0.040 |
Why?
|
Drug Design | 1 | 2002 | 1045 | 0.040 |
Why?
|
Kidney | 4 | 2002 | 7033 | 0.040 |
Why?
|
Reaction Time | 1 | 2003 | 2087 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2005 | 6223 | 0.030 |
Why?
|
Polymorphism, Genetic | 2 | 2012 | 4243 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3778 | 0.030 |
Why?
|
Tryptophan Oxygenase | 3 | 1974 | 19 | 0.030 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2020 | 602 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2004 | 1818 | 0.030 |
Why?
|
Pyrroles | 2 | 2000 | 1124 | 0.030 |
Why?
|
Aging | 2 | 1999 | 8702 | 0.030 |
Why?
|
Electrochemistry | 1 | 1995 | 145 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1995 | 294 | 0.030 |
Why?
|
Polysomnography | 1 | 2002 | 1848 | 0.030 |
Why?
|
Hospitals | 1 | 2008 | 3881 | 0.030 |
Why?
|
COS Cells | 1 | 1996 | 1129 | 0.030 |
Why?
|
beta Catenin | 1 | 2020 | 1042 | 0.030 |
Why?
|
Fluorescent Dyes | 3 | 1992 | 1901 | 0.030 |
Why?
|
Sex Factors | 1 | 2008 | 10553 | 0.030 |
Why?
|
Solubility | 5 | 1983 | 1085 | 0.030 |
Why?
|
Dietary Carbohydrates | 3 | 1974 | 891 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 74239 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3702 | 0.030 |
Why?
|
Isoelectric Focusing | 2 | 1985 | 149 | 0.030 |
Why?
|
Age Factors | 2 | 2008 | 18384 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3726 | 0.030 |
Why?
|
Conditioning, Operant | 2 | 1992 | 309 | 0.030 |
Why?
|
Models, Neurological | 2 | 1998 | 1769 | 0.030 |
Why?
|
Self Administration | 2 | 1991 | 387 | 0.030 |
Why?
|
Genotype | 2 | 2013 | 12985 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2451 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2007 | 18926 | 0.030 |
Why?
|
Biological Transport | 1 | 1997 | 2080 | 0.030 |
Why?
|
Biotin | 2 | 1992 | 251 | 0.030 |
Why?
|
Bicuculline | 2 | 1983 | 96 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7571 | 0.020 |
Why?
|
Oxadiazoles | 1 | 1991 | 94 | 0.020 |
Why?
|
Brain Tissue Transplantation | 1 | 1992 | 81 | 0.020 |
Why?
|
Fetal Tissue Transplantation | 1 | 1992 | 138 | 0.020 |
Why?
|
Synaptophysin | 1 | 2011 | 139 | 0.020 |
Why?
|
Diazepam | 2 | 1983 | 215 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 6067 | 0.020 |
Why?
|
Oxidation-Reduction | 2 | 2006 | 2227 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4111 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2020 | 2455 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 1993 | 1376 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4739 | 0.020 |
Why?
|
Pyrazoles | 1 | 2001 | 2010 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 3933 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 1997 | 1027 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2005 | 3534 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1994 | 1535 | 0.020 |
Why?
|
Cost Control | 1 | 2013 | 627 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2006 | 14392 | 0.020 |
Why?
|
Middle Aged | 8 | 2013 | 220853 | 0.020 |
Why?
|
Fluoresceins | 1 | 1990 | 235 | 0.020 |
Why?
|
Carbon Dioxide | 3 | 1969 | 1147 | 0.020 |
Why?
|
Cerebral Cortex | 2 | 1983 | 5775 | 0.020 |
Why?
|
Genetic Variation | 1 | 2005 | 6567 | 0.020 |
Why?
|
Risk Management | 1 | 2013 | 557 | 0.020 |
Why?
|
Glucose | 4 | 1994 | 4342 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 16952 | 0.020 |
Why?
|
Yohimbine | 1 | 1969 | 62 | 0.020 |
Why?
|
Isoxazoles | 1 | 2010 | 233 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1990 | 2087 | 0.020 |
Why?
|
Time Factors | 8 | 2005 | 39957 | 0.020 |
Why?
|
5-Hydroxytryptophan | 1 | 1968 | 32 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2012 | 1989 | 0.020 |
Why?
|
Pyridines | 1 | 2000 | 2872 | 0.020 |
Why?
|
Digitonin | 3 | 1982 | 25 | 0.020 |
Why?
|
Nerve Fibers | 1 | 1992 | 707 | 0.020 |
Why?
|
Depressive Disorder, Major | 1 | 2006 | 4767 | 0.020 |
Why?
|
Pituitary Gland | 1 | 1990 | 634 | 0.020 |
Why?
|
Child | 3 | 2002 | 80152 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2008 | 39126 | 0.020 |
Why?
|
Chromatography, Thin Layer | 1 | 2006 | 213 | 0.020 |
Why?
|
Hydrazines | 1 | 1968 | 222 | 0.020 |
Why?
|
Mice | 3 | 2020 | 81326 | 0.020 |
Why?
|
Serum Albumin | 3 | 1974 | 674 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2006 | 36415 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2006 | 119 | 0.020 |
Why?
|
Osmosis | 1 | 2006 | 103 | 0.020 |
Why?
|
Simian immunodeficiency virus | 1 | 2011 | 810 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14675 | 0.020 |
Why?
|
Cattle | 2 | 1982 | 3818 | 0.020 |
Why?
|
Butaclamol | 1 | 1985 | 5 | 0.020 |
Why?
|
Fluphenazine | 1 | 1985 | 35 | 0.020 |
Why?
|
Chlorpromazine | 1 | 1985 | 111 | 0.020 |
Why?
|
Huntington Disease | 1 | 1992 | 1145 | 0.010 |
Why?
|
Dialysis | 2 | 1974 | 73 | 0.010 |
Why?
|
Aged | 5 | 2013 | 169288 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 1728 | 0.010 |
Why?
|
Reference Values | 1 | 1991 | 4921 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2004 | 286 | 0.010 |
Why?
|
Receptors, Histamine | 1 | 1983 | 23 | 0.010 |
Why?
|
Hemodynamics | 1 | 1994 | 4165 | 0.010 |
Why?
|
Quinolinic Acid | 2 | 1994 | 67 | 0.010 |
Why?
|
Buffers | 1 | 1983 | 143 | 0.010 |
Why?
|
Lipid Peroxides | 1 | 1983 | 74 | 0.010 |
Why?
|
Apomorphine | 2 | 1994 | 149 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2011 | 1432 | 0.010 |
Why?
|
Tromethamine | 1 | 1982 | 31 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 2468 | 0.010 |
Why?
|
Microglia | 1 | 2011 | 1358 | 0.010 |
Why?
|
Adrenalectomy | 3 | 1969 | 346 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 2006 | 961 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2008 | 64681 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2011 | 1784 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 3418 | 0.010 |
Why?
|
Brain Mapping | 2 | 2006 | 6635 | 0.010 |
Why?
|
Polyethylene Glycols | 2 | 1982 | 1187 | 0.010 |
Why?
|
Amino Acids | 1 | 1965 | 1703 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2189 | 0.010 |
Why?
|
Depression, Chemical | 2 | 1969 | 184 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1983 | 2477 | 0.010 |
Why?
|
Dietary Fats | 3 | 1975 | 1994 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 1981 | 616 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2007 | 11067 | 0.010 |
Why?
|
Chemistry | 2 | 1991 | 325 | 0.010 |
Why?
|
Chemical Phenomena | 2 | 1991 | 484 | 0.010 |
Why?
|
MPTP Poisoning | 1 | 1996 | 37 | 0.010 |
Why?
|
Genomics | 1 | 2012 | 5828 | 0.010 |
Why?
|
Oleic Acids | 2 | 1974 | 72 | 0.010 |
Why?
|
Macrophages | 1 | 2011 | 5753 | 0.010 |
Why?
|
Adrenal Glands | 2 | 1969 | 552 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2006 | 8998 | 0.010 |
Why?
|
Isotope Labeling | 1 | 1996 | 393 | 0.010 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 1974 | 93 | 0.010 |
Why?
|
Oxygen | 1 | 2006 | 4227 | 0.010 |
Why?
|
Iron | 1 | 1983 | 1790 | 0.010 |
Why?
|
Acetylcholinesterase | 1 | 1994 | 156 | 0.010 |
Why?
|
Milk | 1 | 1975 | 440 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1994 | 370 | 0.010 |
Why?
|
Ibotenic Acid | 1 | 1992 | 59 | 0.010 |
Why?
|
Affinity Labels | 1 | 1992 | 107 | 0.010 |
Why?
|
Electroshock | 1 | 1991 | 120 | 0.010 |
Why?
|
Drug Interactions | 1 | 1996 | 1417 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1992 | 333 | 0.010 |
Why?
|
Neurotoxins | 1 | 1992 | 240 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1974 | 927 | 0.010 |
Why?
|
Levodopa | 1 | 1991 | 222 | 0.010 |
Why?
|
Nomifensine | 1 | 1989 | 14 | 0.010 |
Why?
|
Papio | 1 | 1992 | 669 | 0.010 |
Why?
|
Movement Disorders | 1 | 1994 | 459 | 0.010 |
Why?
|
Muscles | 1 | 1974 | 1568 | 0.010 |
Why?
|
Biogenic Monoamines | 1 | 1989 | 50 | 0.010 |
Why?
|
Tyrosine | 1 | 1974 | 1422 | 0.010 |
Why?
|
Stereotaxic Techniques | 1 | 1992 | 555 | 0.010 |
Why?
|
Intestine, Small | 1 | 1974 | 1207 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2013 | 58952 | 0.000 |
Why?
|
Betaine | 1 | 1968 | 90 | 0.000 |
Why?
|
Tryptamines | 1 | 1968 | 93 | 0.000 |
Why?
|
Leukemia, Experimental | 1 | 1968 | 225 | 0.000 |
Why?
|
Bupropion | 1 | 1989 | 304 | 0.000 |
Why?
|
Heme | 1 | 1969 | 313 | 0.000 |
Why?
|
Ligases | 1 | 1968 | 333 | 0.000 |
Why?
|
Asparaginase | 1 | 1968 | 239 | 0.000 |
Why?
|
Xanthurenates | 1 | 1965 | 6 | 0.000 |
Why?
|
Light | 1 | 1992 | 1348 | 0.000 |
Why?
|
Kynurenic Acid | 1 | 1965 | 44 | 0.000 |
Why?
|
Colorimetry | 1 | 1965 | 149 | 0.000 |
Why?
|
Urine | 1 | 1965 | 362 | 0.000 |
Why?
|
Body Weight | 1 | 1974 | 4618 | 0.000 |
Why?
|
Transplantation, Heterologous | 1 | 1992 | 2381 | 0.000 |
Why?
|
Spleen | 2 | 1968 | 2290 | 0.000 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 1992 | 2024 | 0.000 |
Why?
|
Blood Glucose | 2 | 1974 | 6392 | 0.000 |
Why?
|
Case-Control Studies | 1 | 1999 | 22174 | 0.000 |
Why?
|
Chemical Precipitation | 1 | 1981 | 175 | 0.000 |
Why?
|
Liver | 2 | 1974 | 7514 | 0.000 |
Why?
|
Graft Survival | 1 | 1992 | 3843 | 0.000 |
Why?
|
Diet | 2 | 1975 | 8048 | 0.000 |
Why?
|
Insulin | 1 | 1974 | 6588 | 0.000 |
Why?
|
Receptors, GABA-A | 1 | 1983 | 621 | 0.000 |
Why?
|
Pancreas | 1 | 1965 | 1684 | 0.000 |
Why?
|
Neurotransmitter Agents | 1 | 1981 | 664 | 0.000 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1983 | 1139 | 0.000 |
Why?
|
Intestinal Mucosa | 1 | 1965 | 3031 | 0.000 |
Why?
|
Myocardium | 1 | 1965 | 4746 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1992 | 18220 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1973 | 683 | 0.000 |
Why?
|
Dietary Proteins | 1 | 1975 | 951 | 0.000 |
Why?
|
Benz(a)Anthracenes | 1 | 1968 | 11 | 0.000 |
Why?
|
Methylcholanthrene | 1 | 1968 | 30 | 0.000 |
Why?
|
Leukemia, Radiation-Induced | 1 | 1968 | 39 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1992 | 20588 | 0.000 |
Why?
|
Asparagine | 1 | 1968 | 120 | 0.000 |
Why?
|
Diethylstilbestrol | 1 | 1968 | 87 | 0.000 |
Why?
|
Lung | 1 | 1965 | 9979 | 0.000 |
Why?
|
Fasting | 1 | 1973 | 1603 | 0.000 |
Why?
|
Testis | 1 | 1968 | 781 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1968 | 2010 | 0.000 |
Why?
|
Thymus Gland | 1 | 1968 | 1243 | 0.000 |
Why?
|
Estrogens | 1 | 1968 | 1522 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1968 | 3461 | 0.000 |
Why?
|